URBAN ONE INC (UONEK) Fundamental Analysis & Valuation

NASDAQ:UONEK • US91705J4022

Current stock price

4.9543 USD
-0.02 (-0.42%)
Last:

This UONEK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. UONEK Profitability Analysis

1.1 Basic Checks

  • In the past year UONEK has reported negative net income.
  • UONEK had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: UONEK reported negative net income in multiple years.
  • Each year in the past 5 years UONEK had a positive operating cash flow.
UONEK Yearly Net Income VS EBIT VS OCF VS FCFUONEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • The Return On Assets of UONEK (-24.77%) is worse than 68.13% of its industry peers.
  • With a Return On Equity value of -596.96%, UONEK is not doing good in the industry: 80.22% of the companies in the same industry are doing better.
  • With a decent Return On Invested Capital value of 3.27%, UONEK is doing good in the industry, outperforming 62.64% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for UONEK is in line with the industry average of 7.76%.
Industry RankSector Rank
ROA -24.77%
ROE -596.96%
ROIC 3.27%
ROA(3y)-11.92%
ROA(5y)-6.04%
ROE(3y)-219.29%
ROE(5y)-126.91%
ROIC(3y)5.89%
ROIC(5y)6.84%
UONEK Yearly ROA, ROE, ROICUONEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

  • UONEK's Operating Margin of 5.80% is fine compared to the rest of the industry. UONEK outperforms 63.74% of its industry peers.
  • UONEK's Operating Margin has declined in the last couple of years.
  • UONEK has a Gross Margin of 68.60%. This is amongst the best in the industry. UONEK outperforms 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of UONEK has remained more or less at the same level.
Industry RankSector Rank
OM 5.8%
PM (TTM) N/A
GM 68.6%
OM growth 3Y-40.81%
OM growth 5Y-31.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.8%
GM growth 5Y-1.08%
UONEK Yearly Profit, Operating, Gross MarginsUONEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. UONEK Health Analysis

2.1 Basic Checks

  • UONEK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • UONEK has less shares outstanding than it did 1 year ago.
  • UONEK has less shares outstanding than it did 5 years ago.
  • UONEK has a worse debt/assets ratio than last year.
UONEK Yearly Shares OutstandingUONEK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
UONEK Yearly Total Debt VS Total AssetsUONEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • UONEK has an Altman-Z score of -1.38. This is a bad value and indicates that UONEK is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.38, UONEK is doing worse than 73.63% of the companies in the same industry.
  • UONEK has a Debt/Equity ratio of 17.87. This is a high value indicating a heavy dependency on external financing.
  • UONEK has a worse Debt to Equity ratio (17.87) than 80.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 17.87
Debt/FCF N/A
Altman-Z -1.38
ROIC/WACC0.38
WACC8.68%
UONEK Yearly LT Debt VS Equity VS FCFUONEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • UONEK has a Current Ratio of 2.10. This indicates that UONEK is financially healthy and has no problem in meeting its short term obligations.
  • UONEK has a Current ratio of 2.10. This is in the better half of the industry: UONEK outperforms 76.92% of its industry peers.
  • A Quick Ratio of 2.10 indicates that UONEK has no problem at all paying its short term obligations.
  • UONEK's Quick ratio of 2.10 is fine compared to the rest of the industry. UONEK outperforms 79.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1
UONEK Yearly Current Assets VS Current LiabilitesUONEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. UONEK Growth Analysis

3.1 Past

  • UONEK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.70%.
  • The Revenue for UONEK has decreased by -16.75% in the past year. This is quite bad
  • The Revenue has been decreasing by -0.10% on average over the past years.
EPS 1Y (TTM)-44.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180%
Revenue 1Y (TTM)-16.75%
Revenue growth 3Y-8.24%
Revenue growth 5Y-0.1%
Sales Q2Q%-16.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UONEK Yearly Revenue VS EstimatesUONEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

Find the best growth stocksShow best growing peers

1

4. UONEK Valuation Analysis

4.1 Price/Earnings Ratio

  • UONEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UONEK Price Earnings VS Forward Price EarningsUONEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UONEK is valued cheaper than 91.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.96
UONEK Per share dataUONEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UONEK Dividend Analysis

5.1 Amount

  • UONEK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UONEK Fundamentals: All Metrics, Ratios and Statistics

URBAN ONE INC

NASDAQ:UONEK (4/24/2026, 8:12:32 PM)

4.9543

-0.02 (-0.42%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-12
Earnings (Next)05-13
Inst Owners27.65%
Inst Owner Change-100%
Ins Owners54.47%
Ins Owner Change-0.03%
Market Cap22.34M
Revenue(TTM)374.37M
Net Income(TTM)-146.87M
Analysts84.44
Price TargetN/A
Short Float %0.82%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF 5.37
P/B 0.91
P/tB N/A
EV/EBITDA 4.96
EPS(TTM)-32.93
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.31
FCFYN/A
OCF(TTM)0.92
OCFY18.62%
SpS83.01
BVpS5.46
TBVpS-72.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -24.77%
ROE -596.96%
ROCE 4.22%
ROIC 3.27%
ROICexc 3.43%
ROICexgc 11.53%
OM 5.8%
PM (TTM) N/A
GM 68.6%
FCFM N/A
ROA(3y)-11.92%
ROA(5y)-6.04%
ROE(3y)-219.29%
ROE(5y)-126.91%
ROIC(3y)5.89%
ROIC(5y)6.84%
ROICexc(3y)7.08%
ROICexc(5y)7.86%
ROICexgc(3y)41.44%
ROICexgc(5y)39.63%
ROCE(3y)7.48%
ROCE(5y)8.67%
ROICexgc growth 3Y-32.42%
ROICexgc growth 5Y-27.94%
ROICexc growth 3Y-28.62%
ROICexc growth 5Y-20.8%
OM growth 3Y-40.81%
OM growth 5Y-31.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.8%
GM growth 5Y-1.08%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 17.87
Debt/FCF N/A
Debt/EBITDA 5.11
Cap/Depr 15.66%
Cap/Sales 2.69%
Interest Coverage 0.4
Cash Conversion 4.84%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z -1.38
F-Score4
WACC8.68%
ROIC/WACC0.38
Cap/Depr(3y)13.42%
Cap/Depr(5y)12.57%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.75%
Revenue growth 3Y-8.24%
Revenue growth 5Y-0.1%
Sales Q2Q%-16.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.52%
EBIT growth 3Y-45.69%
EBIT growth 5Y-31.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.9%
OCF growth 3Y-60.42%
OCF growth 5Y-43.75%

URBAN ONE INC / UONEK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of URBAN ONE INC (UONEK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to UONEK.


Can you provide the valuation status for URBAN ONE INC?

ChartMill assigns a valuation rating of 1 / 10 to URBAN ONE INC (UONEK). This can be considered as Overvalued.


How profitable is URBAN ONE INC (UONEK) stock?

URBAN ONE INC (UONEK) has a profitability rating of 4 / 10.


What is the financial health of URBAN ONE INC (UONEK) stock?

The financial health rating of URBAN ONE INC (UONEK) is 4 / 10.